Mia's Feed
Medical News & Research

Emerging Evidence Links Diverse Misfolded Proteins to Alzheimer's and Dementia

Emerging Evidence Links Diverse Misfolded Proteins to Alzheimer's and Dementia

Share this article

New research uncovers over 200 types of misfolded proteins linked to Alzheimer's and dementia, opening new avenues for treatment beyond amyloid plaques.

2 min read

Recent research from Johns Hopkins University has broadened our understanding of the molecular contributors to Alzheimer's disease and dementia. Traditionally, scientific focus centered on amyloid-beta and tau proteins, which form noticeable plaques disrupting neural functions. However, new findings reveal that over 200 different types of misfolded proteins are involved in age-related cognitive decline, even when they do not aggregate into visible amyloid plaques.

In a study involving aging rats, scientists identified numerous proteins that misfold, with more than 200 showing abnormal shapes in rats exhibiting cognitive deficits. This suggests that protein misfolding is far more complex than previously believed and that these improperly folded proteins may interfere with brain function independently of amyloid formation.

The research highlights that misfolded proteins evade the cellular systems designed to target and destroy damaged proteins, which could explain their detrimental effects despite not forming large clumps. This breakthrough opens new avenues for understanding the molecular mechanisms underpinning cognitive decline and indicates potential targets for innovative therapeutic strategies.

Moving forward, scientists plan to use advanced microscopy to examine the structural deformities of these misfolded proteins at the molecular level. Such insights could lead to the development of treatments aimed at preventing or reversing protein misfolding, thereby preserving cognitive health as individuals age.

This study emphasizes that amyloid buildup may be just one part of a larger picture involving numerous proteins that contribute to neurodegenerative processes. Recognizing and targeting these diverse misfolded proteins could significantly impact future approaches to preventing and treating Alzheimer's and related dementias.

Source: [https://medicalxpress.com/news/2025-07-misfolded-proteins-previously-contribute-alzheimer.html]

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative PET Tracer Enhances Detection of Invasive Mold Infections in Cancer and Transplant Patients

A new PET radiotracer, 18F-FDS, offers precise, non-invasive detection of invasive mold infections in immunocompromised patients, improving diagnosis and treatment outcomes.

The Role of TERRA, a Long Non-Coding RNA, in Human Aging and Alzheimer's Disease

New research reveals that the long non-coding RNA TERRA is linked to human aging and early stages of Alzheimer's disease, opening new avenues for biomarker development and understanding neurodegeneration.

Enhancing Cancer Treatment Efficacy by Combining MYC Inhibitors with Metabolic Drugs

New research suggests that combining MYC inhibitors with metabolic drugs like metformin can boost cancer treatment efficacy by targeting tumor energy production pathways. This approach offers hope for more effective therapies against resistant cancers.

Microplastic Exposure and its Potential Role in Alzheimer’s Disease Risk in Genetically Susceptible Mice

New research links microplastic exposure to cognitive deficits and Alzheimer's-like behaviors in genetically at-risk mice, highlighting environmental health concerns.